logo-loader
LON:AVCT

Avacta Group PLC

Recieve alerts
Market:
LON
Market Cap:
£24.39 m
Price
0.00
Change
0%
52 weeks high
49.80
52 weeks low
20.50
;

In brief

At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets.

Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.